1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969; 20:288–299.
2. Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid artery. Shinkei. 1957; 9:37–43.
3. Maeda M, Tsuchida C. "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol. 1999; 20:1836–1838.
4. Fujiwara H, Momoshima S, Kuribayashi S. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol. 2005; 55:224–230.
Article
5. Kawashima M, Noguchi T, Takase Y, Ootsuka T, Kido N, Matsushima T. Unilateral hemispheric proliferation of ivy sign on fluid-attenuated inversion recovery images in moyamoya disease correlates highly with ipsilateral hemispheric decrease of cerebrovascular reserve. AJNR Am J Neuroradiol. 2009; 30:1709–1716.
Article
6. Mori N, Mugikura S, Higano S, Kaneta T, Fujimura M, Umetsu A, et al. The leptomeningeal "ivy sign" on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol. 2009; 30:930–935.
Article
7. Ishikawa T, Kuroda S, Nakayama N, Terae S, Kudou K, Iwasaki Y. Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir (Tokyo). 2005; 45:495–500.
8. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, et al. Asymptomatic microbleeds in moyamoya disease: T2
*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg. 2005; 102:470–475.
Article
9. Kuroda S, Kashiwazaki D, Ishikawa T, Nakayama N, Houkin K. Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease: a prospective T2*-weighted MRI study. Stroke. 2013; 44:516–518.
10. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Research Committee on Moyamoya Disease in Japan. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007; 38:1430–1435.
Article
11. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis. Neurol Med Chir (Tokyo). 2012; 52:245–266.
12. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997; 99:Suppl 2. S238–S240.
13. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003; 34:1126–1129.
Article
14. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008; 39:42–47.
Article
15. Hoshino H, Izawa Y, Suzuki N. Research Committee on Moyamoya Disease. Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo). 2012; 52:295–298.
Article